Symbols / LYT
LYT Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | $0.00 |
| Price | $0.10 | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
News
RSS: Latest LYT news- Want to make faster city buses? One city found an answer. - Yello by Hunter Schwarz hu, 19 Feb 2026 21
- New IPF treatment from PureTech gets rare-disease boost in US and Europe - Stock Titan hu, 19 Feb 2026 17
- PureTech’s Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome - Business Wire Fri, 05 Dec 2025 08
- Lytus Technologies Faces Nasdaq Delisting, Plans OTC Market Transition - TipRanks ue, 01 Apr 2025 07
- Lytus Technologies Adjusts Market Strategy and Transition to OTC Markets - Yahoo Finance Mon, 31 Mar 2025 07
- Lytus Technologies Holdings Reports 24% Revenue Growth and Returns to Profitability in Financial Results for Six Months Ended September 30, 2024 - Nasdaq Mon, 17 Mar 2025 07
- 5 Investors Betting Big on Lytus Technologies (LYT) Stock - InvestorPlace hu, 07 Mar 2024 08
- C3.ai, Palo Alto, My Size, And More: 5 Software Stocks That Saw Brisk Activity On Stocktwits Last Week - Stocktwits Mon, 31 Mar 2025 09
- PureTech's Deupirfenidone Shows 91mL Lung Function Benefit in IPF Trial | PRTC Stock News - Stock Titan Mon, 29 Sep 2025 07
- PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis - Business Wire Mon, 08 Dec 2025 08
- LYT-200 Gains FDA Fast Track Status in Acute Myeloid Leukemia - Targeted Oncology ue, 14 Jan 2025 08
- Lytus Technologies Holdings PTV. (LYT) Stock Price, News & Analysis $LYT - MarketBeat Wed, 06 Apr 2022 06
- Sony may sell its smartphone camera business - hi-Tech.ua Fri, 02 May 2025 07
- LYT-200 Gains FDA Orphan Drug Designation in Acute Myeloid Leukemia - Targeted Oncology Wed, 27 Mar 2024 07
- TYSON 2.0 and LYT Holdings Enter Exclusive Licensing Partnership to Strengthen Presence in California - Yahoo Finance ue, 22 Oct 2024 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for LYT
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|